OPERATING AND REPORTABLE SEGMENTS (Tables)

9 Months Ended

Sep. 30, 2014

Segment Reporting [Abstract]

Schedule of Segment Reporting Information, by Segment

Segment Reporting Information

(in thousands)

	Three Months Ended   September 30,						Nine Months Ended   September 30,
	2014			2013			2014			2013
Results of Operations:
Revenue:
Infusion Services - product revenue	$	226,421		$	169,011		$	667,601		$	469,594
Infusion Services - service revenue	5,122			5,614			15,559			15,282
Total Infusion Services revenue	231,543			174,625			683,160			484,876
PBM Services - service revenue	12,416			16,006			47,217			59,098
Total revenue	$	243,959		$	190,631		$	730,377		$	543,974
Adjusted EBITDA by Segment before corporate overhead:
Infusion Services	$	(6,344	)	$	14,623		$	24,811		$	40,615
PBM Services	1,625			4,274			5,137			15,385
Total Segment Adjusted EBITDA	(4,719		)	18,897			29,948			56,000
Corporate overhead	(7,893		)	(7,483		)	(22,385		)	(23,531		)
Interest expense, net	(9,563		)	(7,183		)	(29,197		)	(20,169		)
Loss on extinguishment of debt	—			(15,898		)	—			(15,898		)
Income tax (expense) benefit	(1,930		)	13			(8,484		)	42
Depreciation	(4,205		)	(3,225		)	(11,999		)	(8,169		)
Amortization of intangibles	(1,620		)	(1,009		)	(4,943		)	(4,801		)
Stock-based compensation expense	(1,753		)	(1,427		)	(6,637		)	(7,260		)
Acquisition and integration expenses	(2,922		)	(4,890		)	(14,754		)	(13,025		)
Restructuring and other expenses and investments	(2,970		)	(1,551		)	(12,991		)	(4,604		)
Loss from continuing operations, net of income taxes	$	(37,575	)	$	(23,756	)	$	(81,442	)	$	(41,415	)
Supplemental Operating Data
							September 30, 2014			December 31, 2013
Total Assets:
Infusion Services							$	783,658		$	793,475
PBM Services							29,009			25,239
Corporate unallocated, including cash and cash equivalents							46,169			53,169
Assets from discontinued operations							—			64,959
Assets associated with discontinued operations, not sold							7			16
Total Assets							$	858,843		$	936,858